Kevin Hollevoet

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 3

Top Topics

Circulating Tumor

Top Venues

Cancer gene therapy

Journal of translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Liesl Jacobs, Lidia Yshii, Steffie Junius, Nick Geukens, Adrian Liston, Kevin Hollevoet, Paul J Declerck
Intratumoral DNA-based delivery of checkpoint-inhibiting antibodies and interleukin 12 triggers T cell infiltration and anti-tumor response. Cancer gene therapy (2021)
Giles Vermeire, Elien De Smidt, Peter Casteels, Nick Geukens, Paul J Declerck, Kevin Hollevoet
DNA-based delivery of anti-DR5 Nanobodies improves exposure and anti-tumor efficacy over protein-based administration. Cancer gene therapy 28 (7-8) (2020)
Kevin Hollevoet, Paul J Declerck
State of play and clinical prospects of antibody gene transfer. Journal of translational medicine 15 (1) (2017)